Skip to main content

Jesus Amo-Aparicio, PhD

Postdoctoral at OLATEC Therapeutics LLC

Location: Denver, CO United States

Jesus Amo-Aparicio began his scientific career in 2014 with the objective of modulating the inflammatory response in neurodegenerative diseases. He initially worked in the Group of Neuroplasticity and Regeneration at the Universidad Autonoma de Barcelona, where he studied the inflammatory response after trauma to the Central Nervous System. During his PhD, he published 10 publications in that field and determined the therapeutic potential of three different molecules for the treatment of spinal cord injury. Moreover, he also demonstrated the role of the immunometabolism on the recovery of function after damage. Recently, Dr. Amo-Aparicio moved to the laboratory of Charles A. Dinarello to expand his knowledge in the field of inflammation in a world-renowned laboratory. Right now, he is leading a project to protect dopamine-producing neurons in Parkinson’s disease by the inhibition of IL-1β and IL-18 cytokines.

Associated Grants

  • Assessing the Ability of Dapansutrile, a Selective, Oral Inhibitor of the NLRP3 Neuroinflammatory Pathway, to Mitigate Progression of Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.